We are live on ! Find out more
INAB icon

IN8bio
INAB

15 hedge funds and large institutions have $2.77M invested in IN8bio in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0.02% less ownership

Funds ownership: 4.9% → 4.89% (-0.02%)

7% less capital inflows, than outflows

Capital inflows: $233K | Capital outflows: $251K

12% less funds holding

Funds holding: 17 → 15 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Rock Creek Group
Rock Creek Group
District of Columbia
+$152K
2
Northern Trust
Northern Trust
Illinois
+$24.7K
3
Wells Fargo
Wells Fargo
California
+$18.7K
4
BlackRock
BlackRock
New York
+$15.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.8K

Top Sellers

Rank Fund Capital Flow
1
Precept Management
Precept Management
Texas
-$101K
2
Voss Capital
Voss Capital
Texas
-$70.1K
3
WAM
Warberg Asset Management
Illinois
-$30K
4
United Asset Strategies
United Asset Strategies
New York
-$28K
5
UBS Group
UBS Group
Switzerland
-$9.8K

INAB Hedge Fund Activity: Q4 2022 in Review

15 of the 6,244 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q4 2022, worth a combined $2.77M — up 14% from $2.42M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of INAB and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 5 added.

The largest buyer was Rock Creek Group, opening a new position worth an estimated $152K. The largest seller was Precept Management, exiting entirely with an estimated $101K sold.

  • 15 institutional investors held IN8bio (INAB) as of Q4 2022, down from 17 in Q3 2022.
  • Funds reported $2.77M of IN8bio stock for Q4 2022, up 14% quarter-over-quarter.
  • 3 funds opened new IN8bio positions in Q4 2022 and 5 closed out, a net change of -2 holders.
  • The largest IN8bio buyer in Q4 2022 was Rock Creek Group, an estimated $152K added.
  • The largest IN8bio seller in Q4 2022 was Precept Management, an estimated $101K sold.

Based on aggregated 13F filings for Q4 2022.